Optimum strategies for detection of coronary artery disease and risk assessment Ami E. IskandrianFrans J. Th. Wackers Announcement Pages: A6 - A6
Validation of noninvasive studies for detecting coronary artery disease: Beauty versus blood flow Robert F. Wilson OriginalPaper Pages: S1 - S9
Pharmacologic stress versus maximal-exercise stress for perfusion imaging: Which, when, and why? Manuel D. Cerqueira OriginalPaper Pages: S10 - S14
Tracer selection with different stress modalities based on tracer kinetics Gary V. Heller OriginalPaper Pages: S15 - S21
Are separate normal data files required for quantitative pharmacologic stress radionuclide myocardial perfusion imaging? Frans J. Th. Wackers OriginalPaper Pages: S31 - S40
Risk assessment in patients with stable coronary artery disease: Incremental value of nuclear imaging Daniel S. BermanRory Hachmovitch OriginalPaper Pages: S41 - S49
Risk assessment after myocardial infarction: Have the rules changed with thrombolytic therapy? Mario S. Verani OriginalPaper Pages: S50 - S59
Absolute quantitation of myocardial blood flow: The technical and clinical prospects for single-photon emission computed tomography Jamshid MaddahiJohannes Czernin OriginalPaper Pages: S60 - S65
The role of stress echocardiography versus stress perfusion: A view from the other side Farooq A. Chaudhry OriginalPaper Pages: S66 - S74
